Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS

NCT01141725 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Adult Acute Myeloid Leukemia With Del(5q)
Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
de Novo Myelodysplastic Syndromes
Myelodysplastic Syndrome With Isolated Del(5q)
Untreated Adult Acute Myeloid Leukemia

Interventions

DRUG: bendamustine hydrochloride
DRUG: idarubicin

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]